scholarly article | Q13442814 |
P50 | author | Shruthy Suresh | Q90445208 |
P2093 | author name string | Kathryn A O'Donnell | |
Barrett L Updegraff | |||
Xiaorong Zhou | |||
Yabin Guo | |||
P2860 | cites work | The utility of transposon mutagenesis for cancer studies in the era of genome editing | Q26781762 |
Janus kinase deregulation in leukemia and lymphoma | Q26991810 | ||
Ba/F3 cells and their use in kinase drug discovery | Q33264919 | ||
Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein | Q33682660 | ||
Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors | Q34023887 | ||
Interleukin-3 receptor in acute leukemia | Q34283145 | ||
The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling | Q34304678 | ||
A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis | Q34804602 | ||
Cell of origin strongly influences genetic selection in a mouse model of T-ALL | Q35525387 | ||
Therapeutically Targetable ALK Mutations in Leukemia | Q35676273 | ||
Clonal selection drives genetic divergence of metastatic medulloblastoma | Q35784926 | ||
A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. | Q35991536 | ||
An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model | Q35995227 | ||
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia | Q36174146 | ||
Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions | Q36455108 | ||
Hematopoietic cytokine receptor signaling | Q36970188 | ||
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality | Q37407179 | ||
Sleeping Beauty mutagenesis: exploiting forward genetic screens for cancer gene discovery | Q38198428 | ||
Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis. | Q38811161 | ||
Human somatic cell mutagenesis creates genetically tractable sarcomas | Q38965395 | ||
Activating alleles of JAK3 in acute megakaryoblastic leukemia | Q40255542 | ||
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells | Q40895260 | ||
Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice | Q41959338 | ||
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse | Q42812392 | ||
Interleukin-3 supports growth of mouse pre-B-cell clones in vitro | Q52829763 | ||
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. | Q53356315 | ||
Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. | Q54447711 | ||
Hemopoietic growth factor receptor abnormalities in leukemia | Q62819873 | ||
Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system | Q81251466 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | gene discovery | Q129262352 |
P304 | page(s) | 145-157 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Methods in Molecular Biology | Q15752859 |
P1476 | title | Ex Vivo Transposon-Mediated Genetic Screens for Cancer Gene Discovery | |
P478 | volume | 1907 |
Search more.